RELX PLC (NYSE:RELX) [REL:LN] is awarded a Hold investment rating. My previous article published on December 1, 2023 drew attention to two of the company's businesses, or more specifically, its Risk ...
Exhibition trends: In 2024, RX underlying revenue grew at a slower pace than 2021-2023 after exhibitions revenue declined 69% in 2020 due to COVID. RX reported 2024 revenues of £1,239 million ($1,579 ...
RELX faces technical resistance at $55; I recommend recycling gains into stocks with better momentum. Revenue growth is lackluster, with the key Scientific, Technical & Medical division under pressure ...
RELX, the global provider of information-based analytics and decision tools, reports underlying revenue growth for the first nine months of 2024 and reaffirms the outlook for the full year. We ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results